iBio, Inc.IBIONYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank79
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P79
Within normal range
vs 2Y Ago
11.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202560.31%
2024-49.79%
20235.09%
2022-1.62%
2021179.57%
2020-34.73%
201937.33%
2018-3.18%
201730.45%
2016-9.70%